BEIJING, Aug. 03, 2026 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that orelabrutinib, in combination with mesutoclax (ICP-248), has been granted Breakthrough Therapy Designation (BTD) by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) for the treatment of patients with marginal zone lymphoma (MZL) who have received at least one prior therapy. Orelabrutinib is a novel Bruton’s tyrosine kinase (BTK) inhibitor developed by InnoCare for the treatment of cancers and autoimmune diseases. With its high target selectivity, it minimizes off-target effects, thereby improving both safety and efficacy. Mesutoclax is a novel, oral BCL2 inhibitor developed by InnoCare...

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) — ARC Group Securities Acquisition I (the “Company”) announced today the pricing of its initial public offering of 10,500,000 units at a price of $10.00 per unit. The units are expected to be listed for trading on the Nasdaq Stock Market LLC under the ticker symbol “FJDIU” beginning August 4, 2026. Each unit consists of one Class A ordinary share, one redeemable warrant of the Company, and one right to receive one-fourth (1/4) of one Class A ordinary share upon the consummation of an initial business combination. Each warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Once the securities comprising the units begin separate trading, the Company expects that its Class A ordinary shares, warrants and rights...

Project Made Possible Through Partnership with Department of Water Resources, Self-Help Enterprises SAN JOSE, Calif, Aug. 03, 2026 (GLOBE NEWSWIRE) — Residents along Harrison Road at Avenue 266 now have safe, clean, reliable drinking water for their everyday and emergency needs, thanks to a partnership among California Water Service (Cal Water), the County of Tulare, the State of California’s Department of Water Resources (DWR), and Self-Help Enterprises. This project extended Cal Water’s water main to connect 27 customers whose wells had gone dry. More than $1.3 million in funding was secured for the project through a direct allocation of the County’s American Recovery Plan Act (ARPA) funding and DWR’s Small Community Drought Relief Program to the County of Tulare. With the grant, crews installed 2,265 feet of 8-inch pipe and...

HOUSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of July 31, 2026. As of July 31, 2026, the Company’s net assets were $2.8 billion, and its net asset value per share was $16.49. As of July 31, 2026, the Company’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 667% and the Company’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 515%.STATEMENT OF ASSETS AND LIABILITIESJULY 31, 2026  //  (UNAUDITED)     (in millions)Investments   $       3,917.6  Cash...

NEW YORK and WALTHAM, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced that it granted equity awards on August 3, 2026, to six newly-hired, non-executive employees. The inducement grants were approved by the Company’s independent Compensation Committee and were made as material inducements to acceptance of employment with Dianthus in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement grants consist of non-qualified stock options to purchase an aggregate of 87,000 shares of the Company’s common stock with a 10-year term and an exercise price of $106.02 per share. The options vest as to 25% on the first anniversary...

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) — The Nasdaq Stock Market (Nasdaq: NDAQ) announced today that it has notified NusaTrip Incorporated (Nasdaq: NUTR) that its securities will be delisted from the Nasdaq Stock Market LLC on August 12, 2026, unless the company appeals to a Listing Qualifications Hearings Panel. The securities will remain halted, and unavailable to trade, until any appeal is resolved. Following removal from Nasdaq the securities may be eligible for trading in the over-the-counter market.  Following a temporary trading suspension in the Company’s securities by the U.S. Securities and Exchange Commission (https://www.sec.gov/files/litigation/suspensions/2025/34-104167.pdf) Nasdaq halted trading in the Company’s ordinary shares on October 23, 2025. Nasdaq has now determined that it is appropriate to use its authority under IM-5101-4...

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) — The Nasdaq Stock Market (Nasdaq: NDAQ) announced today that it has notified Magnitude International Ltd. (Nasdaq: MAGH) that its securities will be delisted from the Nasdaq Stock Market LLC on August 12, 2026, unless the company appeals to a Listing Qualifications Hearings Panel. The securities will remain halted, and unavailable to trade, until any appeal is resolved. Following removal from Nasdaq the securities may be eligible for trading in the over-the-counter market.  Following a temporary trading suspension in the Company’s securities by the U.S. Securities and Exchange Commission (https://www.sec.gov/files/litigation/suspensions/2025/34-104317-ts.pdf) Nasdaq halted trading in the Company’s ordinary shares on December 19, 2025. Nasdaq has now determined that it is appropriate to use...

MEXICO CITY, Aug. 03, 2026 (GLOBE NEWSWIRE) — Grupo Aeroméxico S.A.B. de C.V. (NYSE: AERO & BMV: AERO, “Aeroméxico”) reports its July 2026 operational results. Grupo Aeroméxico’s total capacity, measured in available seat miles (ASMs), decreased 1.5% year-over-year, while demand, measured in revenue passenger miles (RPMs), declined 1.9%. Aeroméxico’s July load factor was 88.0%, down 0.4 p.p. compared with July 2025. During the month, Aeroméxico transported 2 million and 157 thousand passengers. Andrés Conesa, Chief Executive Officer stated: “Our July traffic results were in line with our expectations. International demand continued to demonstrate resilience, delivering solid performance across our network. In the domestic market, demand recovered strongly toward the end of the month following the temporary moderation associated...